| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |